GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Guangdong Bawei Biotechnology Corp (BJSE:837023) » Definitions » Debt-to-Equity

Guangdong Bawei Biotechnology (BJSE:837023) Debt-to-Equity : 0.51 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Guangdong Bawei Biotechnology Debt-to-Equity?

Guangdong Bawei Biotechnology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥42.8 Mil. Guangdong Bawei Biotechnology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥153.2 Mil. Guangdong Bawei Biotechnology's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ¥383.2 Mil. Guangdong Bawei Biotechnology's debt to equity for the quarter that ended in Sep. 2024 was 0.51.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Guangdong Bawei Biotechnology's Debt-to-Equity or its related term are showing as below:

BJSE:837023' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.07   Med: 0.45   Max: 0.88
Current: 0.51

During the past 11 years, the highest Debt-to-Equity Ratio of Guangdong Bawei Biotechnology was 0.88. The lowest was 0.07. And the median was 0.45.

BJSE:837023's Debt-to-Equity is ranked worse than
57.15% of 1657 companies
in the Consumer Packaged Goods industry
Industry Median: 0.4 vs BJSE:837023: 0.51

Guangdong Bawei Biotechnology Debt-to-Equity Historical Data

The historical data trend for Guangdong Bawei Biotechnology's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Bawei Biotechnology Debt-to-Equity Chart

Guangdong Bawei Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.62 0.69 0.48 0.45

Guangdong Bawei Biotechnology Quarterly Data
Mar18 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.45 0.44 0.43 0.51

Competitive Comparison of Guangdong Bawei Biotechnology's Debt-to-Equity

For the Household & Personal Products subindustry, Guangdong Bawei Biotechnology's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Bawei Biotechnology's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Guangdong Bawei Biotechnology's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Guangdong Bawei Biotechnology's Debt-to-Equity falls into.



Guangdong Bawei Biotechnology Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Guangdong Bawei Biotechnology's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Guangdong Bawei Biotechnology's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangdong Bawei Biotechnology  (BJSE:837023) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Guangdong Bawei Biotechnology Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Guangdong Bawei Biotechnology's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Bawei Biotechnology Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Xinbei Road, No. 5, Baiyun District, Guangdong Province, Guangzhou, CHN, 510450
Guangdong Bawei Biotechnology Corp is engaged in product planning, formula research and development, manufacturing, and efficacy testing of cosmetics.

Guangdong Bawei Biotechnology Headlines

No Headlines